acquisitionacquisitionsactivityaiapprovalsastrazenecabigbillionbiobiontechbiopharmabreakingbreakthroughsbuzzchallengescontroversiescourtcrisprcutsdealdevelopmentsdosedrugelevidysessentialexpansionfdageneindustryinformedinnovationinsightsinvestmentlatestlillymodernamorningmrnanavigatingnewsnovartisopportunitiespfizerpharmaceuticalspolicypricingpromisingregulatoryrocherulingsareptasetbacksoarsstaystockstrategicstrategiessuccesssupremesurgetariffstrendstrialtrumpupdateupdatesvaccineworld